We are live on ! Find out more
CPCM

Cornerstone Partners Capital Management Portfolio holdings

AUM $34.4M
1-Year Est. Return 26.36%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+26.36%
3 Year Est. Return
+51.8%
5 Year Est. Return
+50.1%
10 Year Est. Return
AUM
$40.3M
AUM Growth
+$4.01M
Cap. Flow
-$737K
Cap. Flow %
-1.83%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$239K

Sector Composition

Rank Sector Weight
1 Industrials 1.29%
2 Healthcare 0.53%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNR icon
1
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.9B
$26.3M 65.33%
352,374
USRT icon
2
iShares Core US REIT ETF
USRT
$4.63B
$5.75M 14.27%
97,080
IVV icon
3
iShares Core S&P 500 ETF
IVV
$902B
$4.48M 11.12%
6,858
-537
-7% -$367K
IEFA icon
4
iShares Core MSCI EAFE ETF
IEFA
$196B
$1.99M 4.94%
21,964
-3,555
-14% -$332K
IEMG icon
5
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.02M 2.53%
14,598
-1,829
-11% -$132K
AMPX icon
6
Amprius Technologies
AMPX
$1.68B
$518K 1.29%
30,706
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$7.96B
$214K 0.53%
+2,462
New +$239K
OTF
8
Blue Owl Technology Finance Corp
OTF
$5.36B
-10,054
Closed -$146K

Similar funds

Cornerstone Partners Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Cornerstone Partners Capital Management held 8 positions worth $40.3M, up 11% from $36.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Cornerstone Partners Capital Management's Q1 2026 filing shows 1 new, 3 reduced and 1 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 2,462 shares worth $214K. The largest sale was iShares Core S&P 500 ETF, an estimated $367K.

By sector, the portfolio is most concentrated in Industrials at 1.3% of assets, up from 0.67% a quarter earlier, followed by Healthcare and Financials.

  • Cornerstone Partners Capital Management's largest Q1 2026 buy was Rhythm Pharmaceuticals: 2,462 shares worth $214K.
  • Cornerstone Partners Capital Management's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $367K.
  • Cornerstone Partners Capital Management fully exited Blue Owl Technology Finance Corp in Q1 2026, selling an estimated $146K.
  • Cornerstone Partners Capital Management's ten largest holdings make up 100% of its $40.3M portfolio in Q1 2026.
  • Cornerstone Partners Capital Management opened 1 new position and closed 1 in Q1 2026.
  • Cornerstone Partners Capital Management's portfolio value rose 11% quarter-over-quarter to $40.3M.

Based on Cornerstone Partners Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.